NYSE - Nasdaq Real Time Price • USD
Cardinal Health, Inc. (CAH)
At close: April 19 at 4:00 PM EDT
After hours: April 19 at 6:08 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 14 | 14 | 18 | 18 |
| Avg. Estimate | 1.96 | 1.79 | 7.29 | 7.99 |
| Low Estimate | 1.9 | 1.7 | 7.14 | 7.65 |
| High Estimate | 2.02 | 1.86 | 7.36 | 8.43 |
| Year Ago EPS | 1.74 | 1.55 | 5.79 | 7.29 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 11 | 11 | 15 | 15 |
| Avg. Estimate | 55.96B | 58.86B | 226.97B | 245.91B |
| Low Estimate | 54.9B | 57.99B | 224.71B | 240.62B |
| High Estimate | 56.96B | 60.12B | 229.29B | 248.84B |
| Year Ago Sales | -- | 53.45B | 205.01B | 226.97B |
| Sales Growth (year/est) | -- | 10.10% | 10.70% | 8.30% |
Earnings History
| CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
|---|---|---|---|---|
| EPS Est. | 1.49 | 1.49 | 1.4 | 1.6 |
| EPS Actual | 1.74 | 1.55 | 1.73 | 1.82 |
| Difference | 0.25 | 0.06 | 0.33 | 0.22 |
| Surprise % | 16.80% | 4.00% | 23.60% | 13.70% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 1.96 | 1.79 | 7.29 | 7.99 |
| 7 Days Ago | 1.96 | 1.79 | 7.3 | 8.01 |
| 30 Days Ago | 1.96 | 1.79 | 7.3 | 8.01 |
| 60 Days Ago | 1.96 | 1.79 | 7.3 | 8.01 |
| 90 Days Ago | 1.89 | 1.74 | 6.95 | 7.68 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | 1 | 1 |
| Up Last 30 Days | -- | -- | 1 | 1 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | 1 | 1 | 1 | 1 |
Growth Estimates
| CURRENCY IN USD | CAH | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 12.60% | -- | -- | 1.60% |
| Next Qtr. | 15.50% | -- | -- | 10.50% |
| Current Year | 25.90% | -- | -- | 5.20% |
| Next Year | 9.60% | -- | -- | 13.30% |
| Next 5 Years (per annum) | 15.27% | -- | -- | 11.22% |
| Past 5 Years (per annum) | 3.10% | -- | -- | -- |
Research Analysis
Analyst Price Targets
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Analyst Recommendations
- Strong Buy
- Buy
- Hold
- Underperform
- Sell
Earnings
Upgrades & Downgrades
| Initiated | Leerink Partners: Outperform | 2/26/2024 |
| Upgrade | Argus Research: Hold to Buy | 2/9/2024 |
| Maintains | UBS: Buy to Buy | 2/5/2024 |
| Maintains | UBS: Buy to Buy | 1/29/2024 |
| Initiated | Barclays: Overweight | 1/3/2024 |
| Initiated | Wells Fargo: Underweight | 12/14/2023 |
Related Tickers
COR Cencora, Inc.
239.13
+0.77%
MCK McKesson Corporation
524.83
+1.16%
OMI Owens & Minor, Inc.
24.79
+3.03%
HSIC Henry Schein, Inc.
70.86
+1.27%
PDCO Patterson Companies, Inc.
26.02
+2.16%
COSM Cosmos Health Inc.
0.4838
-20.17%
EDAP EDAP TMS S.A.
7.26
+1.82%
ZYXI Zynex, Inc.
11.38
-0.61%
AMP.VI Amplifon S.p.A.
31.28
+1.66%
ABC.VI Cencora, Inc.
222.65
0.00%